South San Francisco, CA · Founded 2012 · Privately Held (backing)
Developer of a new generation of macrocycle therapies designed for cell-permeable delivery and can be delivered by multiple routes, including oral administration. Circle Pharma is based in South San Francisco, CA and was founded in 2012. It was valued at $269 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $212 million across 4 recorded rounds; the latest was a $92.4 million later-stage round in Jun 2024.
PMV mark · valuation
$269.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$212.1M
Last round
Later Stage VC
Jun 2024
Cap table — not yet on record
Circle Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Circle Pharma with a free account
·The complete investor list: 23 names
·Watch Circle Pharma: the Monday email on marks, rounds and moves
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Circle Pharma's 4 recorded funding rounds.